Market's view on Advanced Medical Solutions Group
Published on April 2024
- Recent trading has been erratic, with unusual fluctuations in prices and broader spreads between buying and selling prices, suggesting disparity among market makers.
- Market movements hint at potential large buy orders influencing the stock’s price, raising suspicions of further undisclosed buying activity.
- The US market downturn is speculated to impact Ams’ performance post-acquisition approval last month.
- There are expectations for some of Peters’ directors to continue post-acquisition to leverage their expertise in bolstering international sales and improving margins.
- Director share purchases at specific prices have occurred, indicating potential insider confidence.
- Temporary dips in share prices are viewed as blips, with a recovery anticipated due to resolved sales contract issues in the USA and strategic European expansion through the Peters acquisition.
- Market makers are perceived to have benefited from recent activities, with takeover speculations settled by announcements from AMS.
- There is anticipation for upcoming financial results to reflect previously communicated positive trading conditions.
- A key resistance level at 220p is identified, with significant interest in whether this price point can be surpassed and sustained.
- The consensus is that AMS is progressing strategically, with recent acquisitions and product launches expected to drive significant revenue growth and market share expansion in the US.